ESC Premium Access

The clinical experience of J valve transapical transcatheter aortic valve replacement system in high-risk patients with severe pure aortic regurgitation

Congress Presentation

About the speaker

Mr Wei Liu

Beijing Jishuitan Hospital, Beijing (China)
0 follower

6 more presentations in this session

Comparative evaluation of risk model performance for prediction of 30-day mortality in transcatheter aortic valve replacement

Speaker: Mr G. Wolff (Duesseldorf, DE)


Clinical implications of physical function and resilience in patients undergoing transcatheter aortic valve implantation

Speaker: Doctor B. Lindman (Nashville, US)


Multiple and posterior location of moderate paravalvular leaks are associated with worse long-term outcome after successful TAVR

Speaker: Doctor L. Kalinczuk (Warsaw, PL)


Percutaneous mitral edge-to-edge valvuloplasty in end-stage heart failure as a bridge to heart transplant: a case series from a single tertiary referral center.

Speaker: Doctor C. Montalto (Milan, IT)


Risk calculator for prediction of iatrogenic atrial septal defect persistence following percutaneous mitral valve repair

Speaker: Doctor O. Maier (Duesseldorf, DE)


Access the full session

Poster Session 2 - Non-coronary cardiac intervention

Speakers: Mr W. Liu, Mr G. Wolff, Doctor B. Lindman, Doctor L. Kalinczuk, Doctor C. Montalto...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb